Dandan Biotechnology (Shanghai) Co., Ltd., established on 2021-06-09, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Chengdu Lilai Biotechnology Co., Ltd., established on 2008-03-03, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Experimental analysis instrument sales;Environmental protection special equipment sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Import and export;Technology Import and Export;Import and export agency;Laboratory animal cage sales;Animal Husbandry and Fishery Feed Sales;Medical Research and Experimental Development;Research and development of bio-based materials technology.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Supratek Pharma, Inc. develops drugs and related oncology therapeutic products. It offers injectable chemotherapeutic that enhances or enables an approved anticancer drug. The firm’s products include SP1014C - a novel cabazitaxel against drug resistant prostate cancer, SP1030C - novel bendamustine against chronic lymphocytic leukemia and non-Hodgkin’s lymphoma and SP1049C - a novel injectable anthracycline platform drug against chemoresistant cancers. The company was founded by Valery Alakhov in 1994 and is headquartered in Pointe-Claire, Canada.

Vitalgen is a biopharmaceutical company that focuses on the research and development of gene therapeutics. The company is committed to transforming cutting-edge gene and cell therapy technologies into clinically accessible treatments, with the hope of benefiting more many patients. It utilizes CRISPR gene-editing technology to research and develop revolutionary gene therapy to significantly improve the quality of life of patients. Vitalgen was founded in 2020 and is headquartered in Shanghai, China.

Shanghai Taichang Biotechnology Co., Ltd., established on 2020-11-23, Business scope includes general items:engaged in biotechnology,Technical services in the field of medical technology,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Ruifengkang Biomedical Technology (Zhejiang) Co., Ltd., established on 2020-05-14, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Human stem cell technology development and application;Biomass Energy Technology Services;Development of Human Gene Diagnosis and Therapy Technology;Biochemical product technology research and development;Information Consulting Service(Not including licensing information consulting services);internet data service;Medical Research and Experimental Development;hospital management;Conference and Exhibition Services;Health Consulting Services(Does not include medical services);business management;Wholesale of protective equipment for medical staff;Wholesale medical masks;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Production of Class I Medical Devices;Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Class III Medical Device Leasing;Inspection and testing service;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Part of Sichuan Animtech Feed Co. Ltd., Sichuan Huasun Animal Biological Products Co. Ltd. is a company headquartered in Chengdu, China, that manufactures and distributes veterinary vaccines and other animal biological products. On December 26, 2012 Sichuan Animtech Feed Co. Ltd. acquired Sichuan Huasun Animal Biological Products Co. Ltd. from Chengdu Huasun Technology Group Inc., Ltd. for $1.58 million.

Tianjin Medical University General Hospital (Chinese: 天津医科大学总医院) is a general hospital in the central Heping District of the Chinese metropolis of Tianjin, associated with Tianjin Medical University.

Shenzhen Wingor Bio-technology Co., Ltd. engages in the research and development, and production of anti-tumor biological immune cell products. It offers chimeric antigen receptor T lymphocyte, clustered regulatory interspaced short palindromic repeat, mesenchymal stem cell, methyl triazeno imidazole carboxamide technology, and cryobiomedical technology. The company was founded on March 12, 2013 and is headquartered in Shenzhen, China.

Guangdong Wanhai Cell Biotechnology Co., Ltd., established on 2015-12-15, The scope of business includes the R&D and promotion of cellular immunotherapy and stem cell therapy technology;Biotechnology Services and Consulting;Research and development of bioengineering technology,technology transfer,technical consulting;biological reagent,R&D and sales of consumables and instruments(Does not contain drugs);medicine,Biological product,Research and Development of Biomaterials,technical consulting,technology transfer,Technical Services;Class I medical device,R&D of Class II medical devices,production and sales;cosmetic,skin care products,R & D and sales of health care products;Enterprise management information consulting service;Import and export,Technology Import and Export;cell storage;Health Consulting Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Changchun Hengxiao Biotechnology Co., Ltd., established on 2014-04-22, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Internet Information Service for Medical Devices;Production of hygiene products and single-use medical products;Cosmetic production;food production;food sales;Food Internet Sales;animal husbandry.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Health Consulting Services(Does not include medical services);Sales of hygiene products and single-use medical products;internet sales(Except for products that require a license for sale);Cosmetics Wholesale;Cosmetics Retail;Food Internet Sales(Only sell prepackaged food);food sales(Only sell prepackaged food);Import and export;Technology Import and Export;Biochemical product technology research and development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiangsu Qitian Gene Biotechnology Co., Ltd., established on 2012-08-29, Business scope includes genetic biological products,Nucleic Acid Amplification Reagents,Nucleic acid detection reagent,Veterinary biological products,Technology research and development of nucleic acid amplification detection instruments,manufacture,Sales;Detection kit(Does not contain drugs,dangerous goods),Research and development of a class of medical devices,Sales;Animal and plant disease control;computer software development,Technical Services;Socio-Economic Information Consulting Services(Does not include investment advice);Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Veterinary drug production;Veterinary drug business;Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)